methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane

We are methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane CAS:3390-61-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane
CAS.NO:3390-61-2
Synonyms:1,1,3,5,5-pentaphenyl-1,3,5-trimethyltrisiloxane; trimethyl pentaphenyl trisiloxane;
Molecular Formula:C33H34O2Si3
Molecular Weight:546.87800
 
Physical and Chemical Properties:
Density:1.09;
Melting point:-25^oC;
Boiling point:245^oC;
Flash point:243^oC;
 
Specification:
Appearance:Colorless to straw-colored liquid
Purity:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used in a variety of applications including: Aerospace, Electronics, Metallurgy, Vacuum Coatings, and Atomic Energy etc.




Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.Methyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide CAS:35511-14-9 It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-carbamic acid benzyl ester CAS:864825-21-8 It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.Sal disódica de guanosina-5'-difosfato CAS:7415-69-2 With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. nearWith the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near